341![DRUG PRIOR AUTHORIZATION COMMITTEE December 18, 2014 TENTATIVE AGENDA 10:[removed]:05 DRUG PRIOR AUTHORIZATION COMMITTEE December 18, 2014 TENTATIVE AGENDA 10:[removed]:05](https://www.pdfsearch.io/img/17d9eb12adf2c6b960adaf4f3589888a.jpg) | Add to Reading ListSource URL: dss.mo.govLanguage: English - Date: 2014-12-15 14:38:11
|
---|
342![The Tangled Web of Addiction and Crime
What We’ve Accomplished • Raised the Public’s awareness of the dangers of Rx Drugs and educated the medical community to be more diligent in their prescribing practices. The Tangled Web of Addiction and Crime
What We’ve Accomplished • Raised the Public’s awareness of the dangers of Rx Drugs and educated the medical community to be more diligent in their prescribing practices.](https://www.pdfsearch.io/img/4e8258207849a4c565e4401a36f42093.jpg) | Add to Reading ListSource URL: www.state.tn.usLanguage: English - Date: 2014-12-11 08:39:28
|
---|
343![LOPID (Gemfibrozil Tablets, USP) DESCRIPTION LOPID® (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for LOPID (Gemfibrozil Tablets, USP) DESCRIPTION LOPID® (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for](https://www.pdfsearch.io/img/87196bf33706c9d5326a49a7f200c40b.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-11-06 11:32:51
|
---|
344![UKPAR Ramipril 1.25 mg, 2.5 mg, 5 mg and 10 mg Capsules PL[removed]Ramipril 1.25 mg Capsules Ramipril 2.5 mg Capsules UKPAR Ramipril 1.25 mg, 2.5 mg, 5 mg and 10 mg Capsules PL[removed]Ramipril 1.25 mg Capsules Ramipril 2.5 mg Capsules](https://www.pdfsearch.io/img/c69daa29d729728014891ab472d7c7b1.jpg) | Add to Reading ListSource URL: www.mhra.gov.ukLanguage: English - Date: 2015-01-08 11:26:51
|
---|
345![A Law Enforcement Perspective
Zohydro First hydrocodone-only opioid narcotic that is reportedly five to ten times more potent than traditional hydrocodone products, and has no abuse-deterrent properties. A Law Enforcement Perspective
Zohydro First hydrocodone-only opioid narcotic that is reportedly five to ten times more potent than traditional hydrocodone products, and has no abuse-deterrent properties.](https://www.pdfsearch.io/img/dab41d1263c021a0ae04947eaa66ff52.jpg) | Add to Reading ListSource URL: www.in.govLanguage: English - Date: 2014-12-17 14:23:23
|
---|
346![July 26 Webinar, Center for Medicaid and CHIP Services, Draft Methodology for Estimating National Average Retail Prices (NARP) for Medicaid Covered Outpatient Drugs July 26 Webinar, Center for Medicaid and CHIP Services, Draft Methodology for Estimating National Average Retail Prices (NARP) for Medicaid Covered Outpatient Drugs](https://www.pdfsearch.io/img/18a7e6c250bde4cb13229d22a86da3a5.jpg) | Add to Reading ListSource URL: medicaid.govLanguage: English - Date: 2014-12-04 14:16:40
|
---|
347![July 26 Webinar, Center for Medicaid and CHIP Services, Draft Methodology for Estimating National Average Retail Prices (NARP) for Medicaid Covered Outpatient Drugs July 26 Webinar, Center for Medicaid and CHIP Services, Draft Methodology for Estimating National Average Retail Prices (NARP) for Medicaid Covered Outpatient Drugs](https://www.pdfsearch.io/img/add0a5342b0e9d005323649f6cb00996.jpg) | Add to Reading ListSource URL: www.medicaid.govLanguage: English - Date: 2014-12-04 14:16:40
|
---|
348![NOTICE: USP Prednisone Tablets RS Lot R001B0 and Performance Verification Test Calculation Tool The certificate for USP Catalog No[removed], Prednisone Tablets RS, Lot R001B0 issued 3 September 2014 has been revised. The NOTICE: USP Prednisone Tablets RS Lot R001B0 and Performance Verification Test Calculation Tool The certificate for USP Catalog No[removed], Prednisone Tablets RS, Lot R001B0 issued 3 September 2014 has been revised. The](https://www.pdfsearch.io/img/07138197f62c3d1d6c454480292ed6fc.jpg) | Add to Reading ListSource URL: www.usp.orgLanguage: English - Date: 2014-10-30 13:57:59
|
---|
349![Arkansas Department of Health Proposed Rules Pertaining to the List of Controlled Substances for the State of Arkansas Public Comments Received A public hearing was conducted September 2, 2014, at 10:00 a.m. in Room #250 Arkansas Department of Health Proposed Rules Pertaining to the List of Controlled Substances for the State of Arkansas Public Comments Received A public hearing was conducted September 2, 2014, at 10:00 a.m. in Room #250](https://www.pdfsearch.io/img/0b61b6534181e9826c272921a6a64a11.jpg) | Add to Reading ListSource URL: www.healthy.arkansas.govLanguage: English - Date: 2014-12-16 15:11:23
|
---|
350![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XELODA safely and effectively. See full prescribing information for XELODA. ------------------------------ CO HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XELODA safely and effectively. See full prescribing information for XELODA. ------------------------------ CO](https://www.pdfsearch.io/img/0629cf095226240c8977d060e40d5418.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-10-17 10:50:06
|
---|